Neutrophil chemotaxis and superoxide production are induced by cross-linking FcγRII receptors

被引:11
作者
Scott-Zaki, P [1 ]
Purkall, D [1 ]
Ruddy, S [1 ]
机构
[1] Virginia Commonwealth Univ, Dept Internal Med, Div Rheumatol Allergy & Immunol, Richmond, VA 23298 USA
关键词
chemotaxis; superoxide; Fc gamma RII; Fc gamma RIIIB;
D O I
10.1006/cimm.2000.1648
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Neutrophils express two types of receptor for the Fc region of IgG, Fc gamma RII and Fc gamma RIIIB. Via these receptors, neutrophils bind IgG complexes that contain more than one IgG molecule. This binding activates functional processes, such as the respiratory burst and chemotaxis. Neutrophils were treated with biotinylated anti-Fc receptor monoclonal antibodies and chemotaxis toward streptavidin, a cross-linking agent, was determined. Cross-linking Fc gamma RII and not Fc gamma RIIIB induced neutrophil chemotaxis. Superoxide production in response to immobilized anti-Fc receptor antibodies was also examined. Anti-Fc gamma RII Fab bound to ELISA plates induced superoxide production, while anti-Fc gamma RIIIB Fab did not. Pretreatment of neutrophils with anti-Fc gamma RII Fab reduced superoxide generated by immobilized anti-Fc gamma RII antibody. The data demonstrate that Fc gamma RII and not Fc gamma RIIIB are responsible for neutrophil chemotaxis and superoxide production upon Fc receptor activation, (C) 2000 Academic Press.
引用
收藏
页码:89 / 93
页数:5
相关论文
共 17 条
[1]  
BRUNKHORST BA, 1992, J BIOL CHEM, V267, P20659
[2]   Activation of human neutrophils by soluble immune complexes:: Role of FcγRII and FcγRIIIb in stimulation of the respiratory burst and elevation of intracellular Ca2+a [J].
Edwards, SW ;
Watson, F ;
Gasmi, L ;
Moulding, DA ;
Quayle, JA .
PHAGOCYTES: BIOLOGY, PHYSIOLOGY, PATHOLOGY, AND PHARMACOTHERAPEUTICS, 1997, 832 :341-357
[3]  
FEISTER AJ, 1988, J IMMUNOL, V141, P228
[4]   COMPLEMENT AND IMMUNOGLOBULINS STIMULATE SUPEROXIDE PRODUCTION BY HUMAN LEUKOCYTES INDEPENDENTLY OF PHAGOCYTOSIS [J].
GOLDSTEIN, IM ;
ROOS, D ;
KAPLAN, HB ;
WEISSMANN, G .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (05) :1155-1163
[5]  
HENSON PM, 1972, J IMMUNOL, V109, P1182
[6]  
HUIZINGA TWJ, 1989, J IMMUNOL, V142, P2365
[7]  
KUNKEL SL, 1995, AGENT ACTION SUPPL, V46, P11
[8]  
LAXDAL T, 1968, J LAB CLIN MED, V71, P638
[9]  
NELSON RD, 1975, J IMMUNOL, V115, P1650
[10]   FC-RECEPTORS [J].
RAVETCH, JV ;
KINET, JP .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :457-492